Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851173 · ClinicalTrials.gov registry record · Phase 2
Cognitive Enhancement Through Transcranial Laser Therapy
A Phase 2 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 2
- Development phase
- 91
- Enrollment target
NCT02851173 is a Phase 2 study that has completed, run by University of Texas at Austin. The registered enrollment target is 91 participants.
The verdict
NCT02851173, a Phase 2 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 91 participants
- Enrollment target
Study Summary
This is a mechanism-driven translational project to test the efficacy of transcranial low-level light/laser therapy (LLLT), for enhancing cognitive function in middle-aged and older adults and participants with Mild Cognitive Impairment.
Interventions
- DEVICE Placebo
- DEVICE LLLT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2016-02-21 |
| Est. Completion | 2020-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02851173
The ClinicalTrials.gov registry entry for NCT02851173 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02851173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02851173 about?
NCT02851173 is a clinical study titled "Cognitive Enhancement Through Transcranial Laser Therapy". This is a mechanism-driven translational project to test the efficacy of transcranial low-level light/laser therapy (LLLT), for enhancing cognitive function in middle-aged and older adults and participants with Mild Cognitive Impairment.
What is the current status of trial NCT02851173?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 91 participants. The study started on 2016-02-21. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT02851173?
The interventions under investigation include: Placebo (DEVICE), LLLT (DEVICE).
Who is sponsoring clinical trial NCT02851173?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.